|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/506 | |
| A61K 39/395 | |||
| A61P 35/00 | |||
| C07K 16/28 |
| (11) | Number of the document | 3191097 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15767683.4 |
| Date of filing the European patent application | 2015-09-11 | |
| (97) | Date of publication of the European application | 2017-07-19 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/049826 |
| Date | 2015-09-11 |
| (87) | Number | WO 2016/040892 |
| Date | 2016-03-17 |
| (30) | Number | Date | Country code |
| 201462050116 P | 2014-09-13 | US | |
| 201462059788 P | 2014-10-03 | US | |
| 201562119060 P | 2015-02-20 | US | |
| 201562199030 P | 2015-07-30 | US |
| (72) |
LEBWOHL, David, US
PETERS, Malte, DE
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | COMBINATION THERAPIES |
| COMBINATION THERAPIES |